Holen Sie sich die Stockscreener-App
87.89
5.02%
-4.65
Schlusskurs vom Vortag:
$92.54
Offen:
$91.81
24-Stunden-Volumen:
457.26K
Relative Volume:
1.37
Marktkapitalisierung:
$1.48B
Einnahmen:
$5.82B
Nettoeinkommen (Verlust:
$-373.54M
KGV:
-3.8983
EPS:
-22.546
Netto-Cashflow:
$-87.01M
1W Leistung:
-6.29%
1M Leistung:
-3.68%
6M Leistung:
+496.57%
1J Leistung:
+174.66%
1-Tages-Spanne:
$82.61
$92.05
1-Wochen-Bereich:
$82.61
$99.19
52-Wochen-Spanne:
$7.48
$133.04
Agilon Health Inc Stock (AGL) Company Profile
Firmenname
Agilon Health Inc
Sektor
Branche
Telefon
562-256-3800
Adresse
440 POLARIS PARKWAY, WESTERVILLE
Compare AGL vs HCA, THC, FMS, EHC, DVA
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AGL
Agilon Health Inc
|
87.89 | 1.56B | 5.82B | -373.54M | -87.01M | -22.55 |
HCA
Hca Healthcare Inc
|
414.45 | 87.96B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
265.91 | 21.95B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
22.74 | 12.47B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
120.21 | 11.93B | 6.07B | 793.80M | 464.40M | 5.9914 |
DVA
Davita Inc
|
176.01 | 11.18B | 13.84B | 1.10B | 1.49B | 10.42 |
Agilon Health Inc Stock (AGL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-20 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2025-08-06 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-04-25 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-04-08 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-10 | Hochstufung | Citigroup | Sell → Neutral |
| 2025-01-10 | Eingeleitet | Needham | Hold |
| 2024-12-16 | Eingeleitet | Macquarie | Neutral |
| 2024-12-11 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-11-11 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-11-08 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-10-30 | Herabstufung | Citigroup | Neutral → Sell |
| 2024-10-02 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-04-22 | Eingeleitet | Citigroup | Neutral |
| 2024-03-06 | Eingeleitet | Barclays | Underweight |
| 2024-02-26 | Herabstufung | Jefferies | Buy → Hold |
| 2024-02-26 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2024-01-08 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-01-08 | Herabstufung | Stifel | Buy → Hold |
| 2024-01-08 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-01-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-01-05 | Herabstufung | Truist | Buy → Hold |
| 2023-12-11 | Herabstufung | Goldman | Buy → Neutral |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-11-21 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-10-20 | Eingeleitet | The Benchmark Company | Buy |
| 2023-06-13 | Eingeleitet | Evercore ISI | In-line |
| 2022-12-09 | Eingeleitet | Stifel | Buy |
| 2022-09-14 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-09-12 | Eingeleitet | Goldman | Buy |
| 2022-09-07 | Fortgesetzt | Truist | Buy |
| 2022-06-24 | Eingeleitet | BTIG Research | Neutral |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2021-10-20 | Eingeleitet | Jefferies | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-05-11 | Eingeleitet | William Blair | Outperform |
| 2021-05-10 | Eingeleitet | BofA Securities | Buy |
| 2021-05-10 | Eingeleitet | Deutsche Bank | Buy |
| 2021-05-10 | Eingeleitet | Goldman | Buy |
| 2021-05-10 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-10 | Eingeleitet | Truist | Buy |
| 2021-05-10 | Eingeleitet | Wells Fargo | Overweight |
| 2021-05-10 | Eingeleitet | Wolfe Research | Outperform |
Alle ansehen
Agilon Health Inc Aktie (AGL) Neueste Nachrichten
Is Agilon Health Inc (AGL) Overvalued After 4.2% Rally? GF Value - GuruFocus
agilon health to Participate in Upcoming Conferences - Yahoo Finance
Agilon Health (NYSE:AGL) Trading Up 5.4%Here's Why - MarketBeat
Q2 Earnings Highlights: agilon health (NYSE:AGL) Vs The Rest Of The Outpatient & Specialty Care Stocks - Yahoo Finance
AQR Capital Management Trims Agilon Health (AGL) Stake Amid Stoc - GuruFocus
agilon health (AGL) insider’s 17-share move is just tax withholding - Stock Titan
Agilon Health (AGL) Q2 2026 Earnings Call Transcript - AOL.com
Agilon Health (AGL) Institutional Ownership 2026 $AGL - MarketBeat
Agilon Health, Inc. (NYSE:AGL) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Bernstein Reaffirms Their Hold Rating on Agilon Health (AGL) - The Globe and Mail
Agilon Health Inc (AGL) Stock Up 9.0% but GF Value Says Overvalued -- GF Score: 71/100 - GuruFocus
Agilon Health (NYSE:AGL) Trading 8.5% HigherHere's What Happened - MarketBeat
Should agilon health’s (AGL) Profit Rebound and Higher Guidance Prompt a Fresh Look From Investors? - simplywall.st
AGL|agilon health inc|Price:92.730|Chg%:-0.910 - TradingKey
5 Insightful Analyst Questions From agilon health’s Q2 Earnings Call - Yahoo Finance
Agilon Health (NYSE:AGL) Valuation Debate Grows After Guidance - Kalkine Media
Why Is AGL Stock Rising Today? - Stocktwits
Has Agilon Health (AGL) Outpaced Other Medical Stocks This Year? - Yahoo Finance
AQR Capital discloses 4.15% agilon health (AGL) stake in Schedule 13G/A - Stock Titan
Is Agilon Health Inc (AGL) a Bargain After 10.7% Drop? GF Value Says Undervalued - GuruFocus
Goldman Sachs Group (AGL) discloses 3.9% beneficial stake in agilon health - Stock Titan
Citigroup Upgrades Agilon Health to Neutral From Sell, Adjusts Price Target to $115 From $105 - marketscreener.com
Citi Maintains Agilon Health(AGL.US) With Hold Rating, Maintains Target Price $115 - Moomoo
AGILON HEALTH, INC. : CITIGROUP RAISES TO NEUTRAL FROM SELL; RAISES TARGET PRICE TO $115 FROM $105 - Bitget
Agilon Health (AGL) Short Interest & Short Float | Updated Aug 2026 $AGL - marketbeat.com
Citi Upgrades Agilon Health(AGL.US) to Hold Rating, Raises Target Price to $115 - Moomoo
Weekly Recap: Cash, debt & guidance and CHF rollout, clinical expansion - TradingView
Agilon Health Earnings Call Signals Profitable Turnaround - The Globe and Mail
TD Cowen Maintains Agilon Health(AGL.US) With Hold Rating, Raises Target Price to $95 - Moomoo
Can agilon health (AGL) Justify Its Valuation As Earnings Turned Profitable? - Yahoo Finance
agilon health: The Q2 Inflection Is Real (NYSE:AGL) - Seeking Alpha
Analysts Offer Insights on Healthcare Companies: Agilon Health (AGL), Qiagen (QGEN) and Coherus Biosciences (CHRS) - The Globe and Mail
A Quick Look at Today's Ratings for Agilon Health(AGL.US), With a Forecast Between $105 to $140 - Moomoo
Baird Maintains Agilon Health(AGL.US) With Hold Rating, Raises Target Price to $116 - Moomoo
Evercore Maintains Agilon Health(AGL.US) With Hold Rating, Raises Target Price to $125 - Moomoo
agilon health, inc. Stock 12‑Month Price Target Raised to $106.69, Implies 1% Downside - TradingView
Agilon Health (NYSE:AGL) Trading Down 9.9%What's Next? - MarketBeat
agilon health (AGL) Is Up 16.4% After Q2 Return To Profitability And Raised 2026 Outlook - simplywall.st
A Quick Look at Today's Ratings for Agilon Health(AGL.US), With a Forecast Between $105 to $125 - Moomoo
Agilon Health Q2 Earnings Call Highlights - TradingView
AGILON HEALTH, INC. : BENCHMARK RAISES TARGET PRICE TO $140 FROM $95 - Moomoo
Earnings call transcript: Agilon Health tops Q2 2026 estimates and lifts outlook - Investing.com
Agilon Health (AGL) Tops Q2 Earnings and Revenue Estimates - Yahoo Finance
Agilon (AGL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
agilon health, inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Agilon Health (NYSE:AGL) Releases Earnings Results, Beats Estimates By $0.92 EPS - MarketBeat
Agilon: Q2 Earnings Snapshot - Barchart.com
Agilon Health tops Q2 estimates, raises 2026 guidance; Shares gain 3% - Investing.com South Africa
AGL Stock Jumps As Wells Fargo Doubles Price Target - StocksToTrade
(AGL) agilon health, inc. Expects Q3 Revenue Range $1.45B$1.48B - marketscreener.com
agilon health, inc. 2026: Revenue $1.49B, EPS $1.04— 10-Q Summary - TradingView
Finanzdaten der Agilon Health Inc-Aktie (AGL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Agilon Health Inc-Aktie (AGL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Wulf John William | Director |
Nov 12 '25 |
Buy |
0.63 |
81,000 |
50,941 |
365,857 |
0.41%
1.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):